US-Georgia partner Tbilisi Eliava Institute carries out its Vaccine and Bacteriophage studies in its GMP certified Vaccine Center, which we have built at international standards.
US-Georgia partner Tbilisi Eliava Institute carries out its Vaccine and Bacteriophage studies in its GMP certified Vaccine Center, which we have built at international standards.
The biggest medical center in its branch in its region, the international Eliava Institute is conducting vaccine and bacteriophage studies since 1900s in Tbilisi – the capital of Georgia. For many years, Eliava Institute is conducting joint studies with prominent universities in the United States of America. Between our company and the institute, the project and construction contract had been singed in 2016 by aiming to market the products developed in the institute to the European Union and to enhance its manufacturing standards. With the financial aid received from the United Nations, the renovation of the facility was completed in 2017, within a period as short as one year, as a result of the agreement made with our company to meet the European Union Standards. Completed its CMP certification, the facility is carrying out production in international standards.
